These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2454061)

  • 1. Presence in brain of an endogenous ligand for nitrendipine-binding sites that modulates Ca2+ channel activity.
    Hanbauer I; Sanna E
    Ann N Y Acad Sci; 1988; 522():96-105. PubMed ID: 2454061
    [No Abstract]   [Full Text] [Related]  

  • 2. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent Ca2+ channels in primary cultures of cerebellar granule cells: modulatory action by an endogenous ligand.
    Sanna E; Hanbauer I
    Pharmacol Res Commun; 1988 Dec; 20(12):1085-6. PubMed ID: 2850583
    [No Abstract]   [Full Text] [Related]  

  • 4. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
    Haase H; Vetter R; Will H; Will-Shahab L
    Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different localization of receptors for omega-conotoxin and nitrendipine in rat brain.
    Takemura M; Fukui H; Wada H
    Biochem Biophys Res Commun; 1987 Dec; 149(3):982-8. PubMed ID: 2447889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients.
    Desnuelle C; Renaud JF; Delpont E; Serratrice G; Lazdunski M
    Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol turnover as a functional probe for neuronal Ca2+ channels.
    Zernig G; Moshammer T; Glossmann H
    Prog Clin Biol Res; 1988; 252():41-5. PubMed ID: 2450375
    [No Abstract]   [Full Text] [Related]  

  • 9. Voltage-dependence of nitrendipine provides direct evidence for dihydropyridine receptor coupling to calcium channels in intact cat adrenals.
    Artalejo CR; López MG; Moro MA; Castillo CF; de Pascual R; García AG
    Biochem Biophys Res Commun; 1988 Jun; 153(3):912-8. PubMed ID: 2455516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies with enantiomers of dihydropyridine ligands suggests that there are multiple binding sites associated with the calcium channel.
    O'Neill SK; Bolger GT; Triggle CR
    Proc West Pharmacol Soc; 1990; 33():235-41. PubMed ID: 1703308
    [No Abstract]   [Full Text] [Related]  

  • 11. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
    Thorgeirsson G; Rudolph SA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
    Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
    Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
    Bolger GT; Skolnick P
    Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on voltage-operated calcium channels using radioligands.
    Gould RJ; Murphy KM; Snyder SH
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():355-62. PubMed ID: 6327164
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.
    Snyder SH; Reynolds IJ
    N Engl J Med; 1985 Oct; 313(16):995-1002. PubMed ID: 2413355
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in [3H]nitrendipine binding sites in the brain in morphine-tolerant mice.
    Ramkumar V; El-Fakahany EE
    Eur J Pharmacol; 1984 Jul; 102(2):371-2. PubMed ID: 6090166
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological and pharmacological correlates of calcium antagonist receptors.
    Wagner JA; Reynolds IJ; Snyder SH
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S1-9. PubMed ID: 2455102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a Ca2+/calmodulin-dependent binding of the Ca2+ channel antagonist, nitrendipine, to a postsynaptic density fraction isolated from canine cerebral cortex.
    Wu K; Sachs L; Carlin RK; Siekevitz P
    Brain Res; 1986 Nov; 387(2):167-84. PubMed ID: 3024780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.